Hypovolemic Phlebotomy Beneficial Before Liver Resection
WEDNESDAY, Dec. 11, 2024 -- For patients undergoing liver resection, hypovolemic phlebotomy reduces perioperative red blood cell transfusions compared with usual care, according to a study published online Dec. 9 in The Lancet Gastroenterology and Hepatology.
Guillaume Martel, M.D., from the University of Ottawa in Ontario, Canada, and colleagues conducted a superiority, randomized controlled trial to examine whether hypovolemic phlebotomy before liver resection is superior to usual care for reducing red blood cell transfusions. A total of 486 patients were randomly assigned to receive hypovolemic phlebotomy (removal of 7 to 10 mL/kg of whole blood without volume replacement) or usual care (245 and 241 participants, respectively); 22 and 18 patients, respectively, were excluded from the primary analysis population as they did not undergo liver resection.
The researchers found that 8 and 16 percent of patients assigned to hypovolemic phlebotomy and usual care, respectively, had a perioperative red blood cell transfusion by 30 days (difference, −8.8 percentage points; adjusted risk ratio, 0.47). Overall, 17 and 16 percent of patients allocated to hypovolemic phlebotomy and usual care, respectively, had severe complications to 30 days; overall complications to 30 days occurred in 61 and 52 percent, respectively. No postoperative mortality was seen to 90 days.
"Use of hypovolemic phlebotomy before liver transection resulted in significantly fewer perioperative red blood cell transfusions than with usual care," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Read this next
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
WEDNESDAY, Oct. 1, 2025 -- People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated...
Remote Perioperative Telemonitoring Beneficial After Cancer Surgery
THURSDAY, Sept. 25, 2025 -- Remote perioperative telemonitoring (RPM) improves postoperative functional recovery and symptoms among patients undergoing surgery for cancer...
Shunt Surgery Beneficial in Idiopathic Normal-Pressure Hydrocephalus
TUESDAY, Sept. 23, 2025 -- Shunt surgery significantly improves gait velocity at three months among patients with idiopathic normal-pressure hydrocephalus with a response to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.